Latest Automation News

Page 5 of 99
SiteMinder is targeting mid-20s annual recurring revenue growth through FY30 and an adjusted EBITDA margin in the mid-20s, as it positions its hotel commerce platform for an AI-led shift in bookings and revenue management. The company entered that plan after FY26 revenue reached A$266 million and adjusted EBITDA margin rose to 10.6%.
Victor Sage
Victor Sage
28 Oct 2026
Resonance Health has secured an oversubscribed $6.0 million placement to fund MRI endpoint expansion, new TrialsWest sites and development of its non-invasive liver fibrosis device. The raise lifts pro forma net cash to $7.9 million, but the most consequential project remains an investigational technology backed by a small preliminary dataset.
Victor Sage
Victor Sage
27 Oct 2026
Adveritas lifted annualised recurring revenue 47% to $17.9 million while building new customer channels through its SME platform, US partner Vaudit and ChatGPT ad-fraud detection. The growth story is developing alongside a sharp cash-burn warning, with the company reporting 0.82 quarters of funding before its post-quarter-end placement.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Mayne Pharma’s unaudited first-quarter revenue fell 2% to A$95.7 million, while underlying EBITDA dropped 52% as generic competition hit Dermatology. Strong prescription growth in Women’s Health and DistributeRx offered a partial counterweight, alongside progress on key legal disputes.
Victor Sage
Victor Sage
26 Oct 2026
Pureprofile has started FY27 with record quarterly revenue of $18.3 million and EBITDA of $2.4 million, while Platform revenue more than doubled. The ASX-listed data and insights company maintained its revenue guidance and lifted its EBITDA margin outlook to 11% to 12%.
Victor Sage
Victor Sage
26 Oct 2026
Dubber reported $1.3 million of positive operating cash flow in Q1 FY27, alongside $7.7 million in revenue and $16.2 million of total liquidity. The company is now shifting from cost reduction towards growth, with new AI products and the proposed Daisee acquisition next in line.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Saluda Medical delivered 28% FY26 revenue growth and expanded its spinal cord stimulation opportunity with CAP24, but its annual report warns that additional capital may be needed within 12 months. The ASX-listed medical device company also begins FY27 under new CEO Michael Mathias.
Victor Sage
Victor Sage
23 Oct 2026
IPD Group closed FY26 with record revenue and earnings, a higher fully franked dividend and leverage of about 0.3 times underlying EBITDA. The electrical infrastructure provider enters FY27 with its data centre pipeline and Platinum Cables integration carrying much of the growth narrative.
Victor Sage
Victor Sage
23 Oct 2026
Temple & Webster is holding to its FY27 EBITDA target of $33 million to $40 million even as revenue fell 8% in the first months of the year. The online retailer says reduced discounting is depressing sales but improving contribution margins, while AI, private-label products and brand investment move from testing into rollout.
Logan Eniac
Logan Eniac
23 Oct 2026
IKE has lowered its previously indicated FY27 subscription revenue growth expectation of about 35%, citing contract timing rather than weaker demand or churn. The NZX and ASX-listed software company still expects its subscription exit run rate to grow by more than 30% by March 2027, while three new products remain on track for launch.
Sophie Babbage
Sophie Babbage
23 Oct 2026
Wisr has raised its FY27 Cash NPAT guidance by 40% to at least $7 million after record quarterly loan originations lifted its book beyond $1.2 billion. Credit metrics improved alongside the expansion, although net interest margin narrowed as secured vehicle lending became a larger part of the portfolio.
Claire Turing
Claire Turing
22 Oct 2026
Harmoney has reaffirmed its A$16 million-plus FY27 Cash NPAT target after growing its loan book 9% to A$912 million. The new Australian intermediary channel generated A$7 million in loans within two months, while credit quality and margins remained stable.
Claire Turing
Claire Turing
22 Oct 2026

Browse the archive

Full archive